Home > Boards > US OTC > Internet - Online Services > Protagenic Therapeutics Inc. (PTIX)

"HOW LONG UNTIL PROTAGENIC THERAPEUTICS CAN REACH DEFINED

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
point_east Member Profile
 
Followed By 0
Posts 11
Boards Moderated 0
Alias Born 02/14/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2019 4:33:14 PM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 12/23/2019 3:23:48 PM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 12/5/2019 6:02:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2019 10:49:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 4:23:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 2:49:44 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/29/2019 3:05:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 6:06:25 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/26/2019 6:10:36 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:46:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/12/2019 4:27:49 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/3/2019 12:56:40 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 7/3/2019 12:39:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 4:10:51 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 5/16/2019 3:26:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 5:30:19 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/29/2019 5:22:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/25/2019 6:12:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2019 6:17:15 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2019 1:13:06 PM
point_east   Wednesday, 05/30/18 10:44:13 PM
Re: None
Post # of 116961 
"HOW LONG UNTIL PROTAGENIC THERAPEUTICS CAN REACH DEFINED MILESTONES IN THE DEVELOPMENT OF PT00114?"

Protagenic Therapeutics is committed to advancing its biological expertise to help build a strong presence with novel, first-in-class approaches in the treatment of a variety of psychological and psychiatric diseases. We believe that understanding the biology of disease as well as the mechanism of action of a potential intervention will help facilitate more efficient and speedy clinical development while improving the probabilities of success in clinical trials. We expect our IND-enabling studies to be completed by March 2018, followed by IND submission to the FDA in the 2nd quarter of 2018. If this IND is accepted by the FDA, we anticipate being able to commence Phase I clinical trials in 2018.

http://protagenic.com/investors/investor-faq/

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist